UroGen Pharma Ltd.
URGN | NASDAQ
$43.20
-$0.05 (-0.12%)
At close: Sep 21, 2026, 4:00 PM ET
$44.20
+$1 (+2.31%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 188.73M | 140.49M | 109.79M | 96.52M | 94.24M | 91.87M | 90.4M | 89.36M | 85.01M | 84.3M | 82.71M | 77.28M | 72.52M | 67.99M | 64.36M | 62.44M | 57.69M | 54.12M | 48.04M | 39.83M | 31.94M | 19.28M |
Cost of Revenue | 17.28M | 14.26M | 12.45M | 11.63M | 10.8M | 9.48M | 8.88M | 8.7M | 8.61M | 8.82M | 9.36M | 9.34M | 8.99M | 8.39M | 7.65M | 6.98M | 6.2M | 5.79M | 5.16M | 4.22M | 3.29M | 1.91M |
Gross Profit | 171.46M | 126.24M | 97.34M | 84.89M | 83.43M | 82.39M | 81.52M | 80.67M | 76.4M | 75.48M | 73.35M | 67.94M | 63.53M | 59.59M | 56.7M | 55.46M | 51.49M | 48.34M | 42.89M | 35.61M | 28.66M | 17.38M |
Operating Income | -66.65M | -108.21M | -124.86M | -133.41M | -123.57M | -107.96M | -96.78M | -83.73M | -79.69M | -69.23M | -65.54M | -71.21M | -75.8M | -79.13M | -79.04M | -78.67M | -84.03M | -88.14M | -92.29M | -99.63M | -105.32M | -114.29M |
Interest Income | 3.96M | 4.69M | 5.97M | 7.87M | 9.45M | 9.5M | 9.09M | 7M | 5.08M | 3.79M | 2.64M | 2.38M | 1.99M | 1.68M | 1.04M | 591K | 207K | 184K | 349K | 431K | 682K | 1.03M |
Pretax Income | -98.11M | -138.31M | -153.42M | -161.64M | -150.82M | -135.26M | -124.04M | -111.34M | -109.65M | -100.36M | -98.32M | -104.34M | -107.58M | -110.15M | -108.03M | -107.16M | -112.25M | -111.5M | -109.37M | -109.21M | -107.81M | -113.25M |
Net Income | -97.64M | -133.23M | -153.49M | -164.64M | -154.97M | -138.43M | -126.87M | -115.38M | -113.58M | -104.32M | -102.24M | -105.1M | -109.05M | -111.6M | -109.78M | -109.37M | -113.75M | -113.28M | -110.82M | -112.89M | -111.5M | -116.63M |
Selling & General & Admin | 176.85M | 171.62M | 155.1M | 115.75M | 107.11M | 93.96M | 86.3M | 110.85M | 103.66M | 96.1M | 93.27M | 90.36M | 87.67M | 86.01M | 82.84M | 82.62M | 63.55M | 42.72M | 21.42M | 22.16M | 22.16M | 46.18M |
Research & Development | 61.26M | 62.83M | 67.11M | 67.69M | 65.03M | 61.52M | 57.15M | 53.55M | 52.43M | 48.61M | 45.61M | 48.79M | 51.65M | 52.71M | 52.91M | 51.51M | 50.34M | 49.83M | 47.64M | 46.97M | 45.25M | 41.24M |
Other Expenses | n/a | n/a | n/a | 34.86M | 34.86M | 34.86M | 34.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.62M | 43.93M | 66.12M | 66.12M | 66.56M | 44.25M |
Operating Expenses | 238.11M | 234.45M | 222.2M | 218.29M | 207M | 190.34M | 178.3M | 164.4M | 156.09M | 144.71M | 138.89M | 139.15M | 139.33M | 138.72M | 135.74M | 134.13M | 135.52M | 136.47M | 135.18M | 135.25M | 133.97M | 131.67M |
Interest Expense | 34.58M | 38.47M | 33.85M | 24.73M | 19.46M | 14.14M | 12.52M | 12.22M | 13.31M | 13.61M | 14.72M | 19.43M | 18.31M | 16.79M | 13.52M | 12.64M | 16.77M | 17.72M | 17.44M | 10.02M | 3.19M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 255.39M | 248.71M | 234.65M | 229.92M | 217.8M | 199.83M | 187.18M | 173.1M | 164.7M | 153.53M | 148.25M | 148.48M | 148.32M | 147.11M | 143.4M | 141.11M | 141.72M | 142.26M | 140.33M | 139.47M | 137.26M | 133.58M |
Income Tax Expense | -472K | -5.09M | 78K | 3M | 4.15M | 3.17M | 2.83M | 4.04M | 3.94M | 3.95M | 3.92M | 755K | 1.47M | 1.45M | 1.76M | 2.2M | 1.49M | 1.77M | 1.45M | 3.69M | 3.69M | 3.37M |
Shares Outstanding (Basic) | 50.38M | 50.18M | 49.23M | 48.06M | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
Shares Outstanding (Diluted) | 50.38M | 50.18M | 49.23M | 48.06M | 47.74M | 47.42M | 47.03M | 43.1M | 36.82M | 33.38M | 36.15M | 32.3M | 23.46M | 23.28M | 23.09M | 22.8M | 22.7M | 22.63M | 22.43M | 22.38M | 22.33M | 22.24M |
EPS (Basic) | -1.98 | -2.75 | -3.20 | -3.46 | -3.32 | -3.18 | -3.23 | -3.15 | -3.28 | -3.40 | -3.73 | -4.23 | -4.68 | -4.83 | -4.78 | -4.83 | -5.05 | -5.04 | -4.96 | -5.07 | -5.03 | -5.30 |
EPS (Diluted) | -1.98 | -2.75 | -3.20 | -3.46 | -3.32 | -3.18 | -3.23 | -3.15 | -3.28 | -3.40 | -3.73 | -4.23 | -4.68 | -4.83 | -4.78 | -4.83 | -5.05 | -5.04 | -4.96 | -5.07 | -5.03 | -5.30 |
EBITDA | -70.72M | -115.78M | -135.66M | -139.96M | -128.87M | -109.7M | -94.59M | -75.52M | -73.02M | -63.27M | -65.7M | -82.78M | -92.59M | -90.82M | -91.94M | -86.88M | -94.88M | -102.47M | -101.06M | -108.26M | -107.27M | -112.89M |
EBIT | -72.76M | -118.34M | -138.07M | -141.76M | -130.3M | -110.79M | -95.53M | -76.82M | -74.47M | -64.89M | -67.4M | -84.51M | -94.35M | -92.61M | -93.76M | -88.7M | -96.48M | -103.8M | -102.13M | -109.49M | -108.4M | -114.29M |
Depreciation & Amortization | 2.05M | 2.57M | 2.41M | 1.8M | 1.43M | 1.09M | 948K | 1.3M | 1.45M | 1.62M | 1.71M | 1.73M | 1.75M | 1.8M | 1.82M | 1.82M | 1.6M | 1.33M | 1.07M | 1.23M | 1.13M | 1.4M |
Add to Watchlist
Select watchlists to add or remove URGN